Wookey PJ, Gupta P, Bittencourt L, Cheung S, Hare DL, Furness SGB.
Methods to measure calcitonin receptor activity, up-regulated in cell stress, apoptosis and autophagy. F1000Research 10:1019 2021.
Link to publication

Gupta, P, Hare DL, Wookey PJ.
Strategic development of an immunotoxin for the treatment of glioblastoma and other tumours expressing the calcitonin receptor. Cells 10:2347, 2021.
Link to publication

Gupta P, Furness SGB, Bittencourt L, Hare DL, Wookey PJ.
Building the case for the calcitonin receptor as a viable target for the treatment of glioblastoma. Therap Adv Med Oncol, 12:1-15, 2020.

Gilabert-Oriol R, Furness SGB, Stringer BW, Weng A, Fuchs H, Day BW, Kourakis A, Boyd AW, Hare DL, Thakur M, Johns TG, Wookey PJ.
Dianthin-30 or gelonin versus monomethyl auristatin E, each configured with an anti-calcitonin receptor antibody, are differentially potent in vitro in high grade glioma cell lines derived from glioblastoma. Cancer Immunol Immunother 66:1217-1228, 2017

Furness SGB, Hare DL, Kourakis A, Turnley AM, Wookey PJ.
A novel ligand of calcitonin receptor reveals a potential new sensor that modulates programmed cell death. Cell Death Disc 2:16062-16071. 2016

Wookey PJ, McLean CA, Hwang P, Furness SGB, Nguyen S, Kourakis A, Hare DL, Rosenfeld JV.
The expression of calcitonin receptor detected in malignant cells of the brain tumour glioblastoma multiforme and functional properties in the GBM cell line A172. Histopathol 60: 895-910, 2012.
Link to publication

Wookey PJ, Zulli A, Lo C, Hare DL, Schwarer AP, Darby IA, Leung AY.
Calcitonin receptor expression in embryonic, foetal and adult tissues: developmental and pathophysiological implications. In: The calcitonin gene-related family: form, function and future perspectives. Hay, Debbie L and Dickerson, Ian M, eds. Springer, Dordrecht, The Netherlands, pp. 199-233. 2010
Link to publication